CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	$ 988	$ 1,192
Accounts receivable, net of allowance for credit losses of $24 and $15 as of June 30, 2020 and December 31, 2019, respectively	1,126	1,063
Inventories	154	123
Prepaid expenses and other current assets	112	112
Total current assets	2,380	2,490
Property, plant and equipment, net	1,505	1,453
Operating lease right-of-use assets	522	518
Goodwill	6,789	6,619
Intangible assets, net	1,141	1,121
Investments in equity method investees	495	482
Other assets	158	160
Total assets	12,990	12,843
Liabilities and Stockholders' Equity
Accounts payable and accrued expenses	1,142	1,041
Current portion of long-term debt	555	804
Current portion of long-term operating lease liabilities	146	145
Total current liabilities	1,843	1,990
Long-term debt	4,020	3,966
Long-term operating lease liabilities	416	413
Other liabilities	753	711
Commitments and contingencies
Redeemable noncontrolling interest	77	76
Quest Diagnostics stockholders’ equity:
Common stock, par value $0.01 per share; 600 shares authorized as of both June 30, 2020 and December 31, 2019; 217 shares issued as of both June 30, 2020 and December 31, 2019	2	2
Additional paid-in capital	2,764	2,722
Retained earnings	8,307	8,174
Accumulated other comprehensive loss	(55)	(39)
Treasury stock, at cost; 83 and 84 shares as of June 30, 2020 and December 31, 2019, respectively	(5,187)	(5,218)
Total Quest Diagnostics stockholders' equity	5,831	5,641
Noncontrolling interests	50	46
Total stockholders' equity	5,881	5,687
Total liabilities and stockholders' equity	$ 12,990	$ 12,843